ASP Isotopes (NASDAQ:ASPI) Sets New 52-Week Low After Insider Selling

ASP Isotopes Inc. (NASDAQ:ASPI) reached a new 52-week low during trading on Friday after an insider sold shares in the company. The company traded as low as $3.42 and last traded at $3.4280, with a volume of 605382 shares changing hands. The stock had previously closed at $3.59.

Specifically, COO Robert Ainscow sold 8,438 shares of ASP Isotopes stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $4.29, for a total transaction of $36,199.02. Following the transaction, the chief operating officer owned 2,248,441 shares in the company, valued at approximately $9,645,811.89. The trade was a 0.37% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Wall Street Zen upgraded ASP Isotopes from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a research report on Wednesday, June 24th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $13.00.

ASP Isotopes Stock Performance

The company has a debt-to-equity ratio of 0.76, a quick ratio of 3.85 and a current ratio of 3.87. The company has a market capitalization of $525.09 million, a P/E ratio of -2.59 and a beta of 3.59. The business’s fifty day simple moving average is $4.21 and its 200-day simple moving average is $5.16.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings data on Friday, August 14th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.11). The company had revenue of $5.12 million for the quarter, compared to the consensus estimate of $4.47 million. ASP Isotopes had a negative net margin of 427.98% and a negative return on equity of 64.99%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Quantbot Technologies LP bought a new stake in ASP Isotopes in the 3rd quarter valued at $34,000. BNP Paribas Financial Markets boosted its position in ASP Isotopes by 84.9% during the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after purchasing an additional 2,548 shares during the period. State of Wyoming acquired a new position in shares of ASP Isotopes in the first quarter valued at $29,000. Allworth Financial LP acquired a new position in shares of ASP Isotopes in the second quarter valued at $51,000. Finally, Legal & General Group Plc raised its position in shares of ASP Isotopes by 30.4% in the third quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock valued at $81,000 after purchasing an additional 1,953 shares during the period. 16.80% of the stock is currently owned by institutional investors.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.